A. Munck

发表

Recommendations for the classification of diseases as CFTR-related disorders.

B. Kerem, J. Zieleński, P. Pignatti, 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Hypoxia-inducible factor 2α plays a critical role in the formation of alveoli and surfactant.

W. V. van IJcken, A. Günther, F. Grosveld, 2012, American journal of respiratory cell and molecular biology.

CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency

S. Caras, A. Gelrud, A. Munck, 2010, Advances in therapy.

Pancreatic enzyme replacement therapy for young cystic fibrosis patients.

N. Kapel, G. Bellon, A. Munck, 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Clinical outcome of cystic fibrosis presenting with or without meconium ileus: a matched cohort study.

Y. Aigrain, J. Navarro, A. Munck, 2006, Journal of pediatric surgery.

ECFS best practice guidelines: the 2018 revision.

C. Castellani, P. Dřevínek, S. Bell, 2018, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Newborn screening programmes including genetic analyses: limits and risks of negative consequences?

C. Thauvin-Robinet, E. Girodon, A. Munck, 2010, Journal of Epidemiology & Community Health.

The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening

E. Génin, C. Clavel, S. Leroy, 2009, Journal of Medical Genetics.

Causes of death in French cystic fibrosis patients: The need for improvement in transplantation referral strategies!

P. Burgel, A. Munck, C. Hamard, 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Nutrition and Growth in Cystic Fibrosis

J. Navarro, A. Munck, R. Hankard, 2002, Hormone Research in Paediatrics.

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

E. Ingenito, E. Mckone, A. Munck, 2017, The New England journal of medicine.

Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.

I. Pin, J. Gaillard, J. Herrmann, 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis

C. Thauvin-Robinet, I. Sermet-Gaudelus, I. Fajac, 2010, Thorax.

P. Berche, I. Sermet-Gaudelus, J. Gaillard, 2005, Journal of Clinical Microbiology.

Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients

F. Brémont, I. Sermet, A. Munck, 2004, European Respiratory Journal.

Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients.

R. Houwen, M. Wilschanski, A. Munck, 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Does newborn screening influence the young cystic fibrosis cohort included in national registries?

K. De Boeck, A. Munck, V. Gulmans, 2017, European Respiratory Journal.

AGER -429T/C Is Associated with an Increased Lung Disease Severity in Cystic Fibrosis

P. Böelle, P. Reix, J. Dalphin, 2012, PloS one.

A new highly discriminatory multiplex capillary-based MLVA assay as a tool for the epidemiological survey of Pseudomonas aeruginosa in cystic fibrosis patients

D. Sobral, G. Vergnaud, E. Bingen, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

Inconclusive Diagnosis after Newborn Screening for Cystic Fibrosis

A. Munck, 2020, International journal of neonatal screening.

Diagnosis of Cystic Fibrosis in Screened Populations

D. Sanders, M. Rosenfeld, H. Blau, 2017, The Journal of pediatrics.

Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis

P. Lebecque, N. Derichs, K. De Boeck, 2009, Thorax.

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening.

N. Derichs, R. Parad, A. Munck, 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Nutritional considerations in patients with cystic fibrosis

A. Munck, 2010, Expert review of respiratory medicine.

Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization

J. Benichou, P. Reix, I. Pin, 2021, Pulmonary Therapy.

Efficacy response in CF patients treated with ivacaftor: Post‐hoc analysis

J. Elborn, M. Konstan, S. Rodriguez, 2015, Pediatric pulmonology.

Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function.

P. Reix, P. Burgel, J. Paillasseur, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial

F. Ratjen, A. Munck, G. Angyalosi, 2009, Thorax.

Cystic Fibrosis Transmembrane Conductance Regulator‐Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis

A. Munck, K. Southern, T. Gonska, 2017, The Journal of pediatrics.

Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial.

L. Lands, H. Tiddens, K. De Boeck, 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID).

O. Sommerburg, S. McColley, C. Castellani, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Newborn screening for CF in France: An exemplary national experience.

M. Audrézet, A. Munck, A. Munck, 2020, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening

P. Farrell, G. Bellon, A. Munck, 2020, Pediatric pulmonology.

Inconclusive diagnosis after a positive newborn bloodspot screening result for cystic fibrosis; clarification of the harmonised international definition.

S. McColley, C. Castellani, P. Farrell, 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Comprehensive CFTR gene analysis of the French cystic fibrosis screened newborn cohort: implications for diagnosis, genetic counseling, and mutation-specific therapy

M. Claustres, C. Férec, M. Audrézet, 2015, Genetics in Medicine.

CFTR p.Arg117His associated with CBAVD and other CFTR-related disorders

A. Valéri, C. Clavel, G. Karsenty, 2013, Journal of Medical Genetics.

Implementation of the French nationwide cystic fibrosis newborn screening program.

A. Munck, M. Roussey, C. Sahler, 2008, The Journal of pediatrics.

Nutritional Status Improved in Cystic Fibrosis Patients with the G551D Mutation After Treatment with Ivacaftor

S. Schwarzenberg, M. Wilschanski, A. Munck, 2015, Digestive Diseases and Sciences.

Cytomegalovirus colitis in children with inflammatory bowel disease

M. Bellaiche, M. Peuchmaur, A. Munck, 2006, Gut.

Nutritional Status in the First 2 Years of Life in Cystic Fibrosis Diagnosed by Newborn Screening

P. Reix, F. Brémont, A. Munck, 2018, Journal of pediatric gastroenterology and nutrition.

Erratum: Hypoxia inducible factor 3α plays a critical role in alveolarization and distal epithelial cell differentiation during mouse lung development (The PLOS ONE Staff (2013) 8:2 (e57695) DOI: 10.1371/journal.pone.0057695)

W. Ijcken, A. Munck, S. Swagemakers, 2015 .

Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis

A. Munck, E. Jacquemin, D. Moyse, 2009, Journal of clinical pharmacy and therapeutics.

Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.

D. Caimmi, A. Didier, S. Leroy, 2020, American journal of respiratory and critical care medicine.

Retrospective observational study of French patients with cystic fibrosis and a Gly551Asp-CFTR mutation after 1 and 2years of treatment with ivacaftor in a real-world setting.

A. Munck, L. Mély, V. David, 2018, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Optimization of the French cystic fibrosis newborn screening programme by a centralized tracking process

M. Audrézet, A. Munck, D. Cheillan, 2017, Journal of medical screening.

Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization

E. Bingen, A. Munck, S. Bonacorsi, 2001, Pediatric pulmonology.

[Duodenal ulcer - multicenter double-blind study with proglumide].

A. Munck, K. Consentius, D. Stopik, 1981, Medizinische Klinik.

Prevention of recurrence by mesalamine (Pentasa) in pediatric Crohn's disease A multicentric double blind trial

J. Sarles, J. Mary, D. Turck, 2003 .

Neonatal screening for cystic fibrosis: comparing the performances of IRT/DNA and IRT/PAP.

J. Sarles, J. Dagorn, A. Munck, 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Consensus on the Use and Interpretation of Cystic Fibrosis Mutation Analysis in Clinical Practice

B. Kerem, J. Zieleński, P. Pignatti, 2022 .

[The pigmentation of the renal papillae and the mucosa of the urinary tract in chromic sclerosing interstitial nephritis ("Phenacetin-Niere")].

A. Munck, F. Lindlar, W. Masshoff, 1970, Virchows Archiv. A, Pathology. Pathologische Anatomie.

Population Pharmacokinetics of Ciprofloxacin in Pediatric and Adolescent Patients with Acute Infections

Y. Aigrain, A. Munck, Y. Aigrain, 2003, Antimicrobial Agents and Chemotherapy.

[Currarino syndrome: an association not to be overlooked].

P. de Lagausie, Y. Aigrain, A. Munck, 1991, Archives francaises de pediatrie.

European Cystic Fibrosis Society Standards of Care: Best Practice guidelines.

Sarah Jane Schwarzenberg, S. Bell, F. Ratjen, 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

Xiaohong Huang, Michael P Boyle, Carla Colombo, 2015, The New England journal of medicine.

Generation of a biotinylatable Sox 2 mouse model to identify Sox 2 complexes in vivo

Jeroen A. A. Demmers, D. Tibboel, R. Rottier, 2018 .

Up‐to‐date incidence and initial characteristics of cystic fibrosis in Tunisia

A. Munck, K. Boussetta, T. Messaoud, 2022, Pediatric Pulmonology.

CFTR mutations in Turkish and North African cystic fibrosis patients in Europe: implications for screening.

J. Dankert-Roelse, A. Munck, M. Cornel, 2008, Genetic testing.

A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis.

A Munck, K G Brownlee, C Castellani, 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

European survey of newborn bloodspot screening for CF: opportunity to address challenges and improve performance.

O. Sommerburg, C. Castellani, M. Proesmans, 2022, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Explorer SOX 2 redirects the developmental fate of the intestinal epithelium toward a premature gastric phenotype

F. Grosveld, D. Tibboel, R. Rottier, 2017 .

SOX2 redirects the developmental fate of the intestinal epithelium toward a premature gastric phenotype.

F. Grosveld, D. Tibboel, R. Rottier, 2012, Journal of molecular cell biology.

Management of pancreatic, gastrointestinal and liver complications in adult cystic fibrosis.

A. Munck, F. Huet, M. Abély, 2015, Revue des maladies respiratoires.

Ultrasonography Detects Appendicular Mucocele in Cystic Fibrosis Patients Suffering Recurrent Abdominal Pain

P. de Lagausie, J. Navarro, M. Peuchmaur, 2000, Pediatrics.

European best practice guidelines for cystic fibrosis neonatal screening.

O. Sommerburg, M. Macek, C. Férec, 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Defining DIOS and Constipation in Cystic Fibrosis With a Multicentre Study on the Incidence, Characteristics, and Treatment of DIOS

R. Houwen, I. Sermet, M. Wilschanski, 2010, Journal of pediatric gastroenterology and nutrition.

The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe.

O. Sommerburg, C. Castellani, J. Dankert-Roelse, 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

The importance of sweat testing for older siblings of patients with cystic fibrosis identified by newborn screening.

A. Munck, E. Houssin, M. Roussey, 2009, The Journal of pediatrics.

Real life practice of sweat testing in Europe.

N. Derichs, K. De Boeck, M. Wilschanski, 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Hypoxia Inducible Factor 3α Plays a Critical Role in Alveolarization and Distal Epithelial Cell Differentiation during Mouse Lung Development

F. Grosveld, D. Tibboel, R. Rottier, 2013, PloS one.

A survey of newborn screening for cystic fibrosis in Europe.

C. Castellani, J. Dankert-Roelse, A. Munck, 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation.

J. Mainz, J. Davies, C. Wainwright, 2013, American journal of respiratory and critical care medicine.

International prospective study of distal intestinal obstruction syndrome in cystic fibrosis: Associated factors and outcome.

R. Houwen, M. Wilschanski, A. Munck, 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Cystic fibrosis‐related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy *

M. Polak, P. Czernichow, A. Clément, 2001, Acta paediatrica.

Heat Wave and Acute Pancreatitis: Very Unusual Cystic Fibrosis Presentation

A. Munck, 2004, Pediatrics.

Evaluation of Guidelines for Management of Familial Adenomatous Polyposis in a Multicenter Pediatric Cohort

L. Michaud, M. Peuchmaur, A. Munck, 2011, Journal of pediatric gastroenterology and nutrition.

Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension.

B. Dousset, A. Munck, A. Sardet, 1999, Journal of hepatology.

Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up.

J. Navarro, A. Munck, C. Anagnostopoulos, 1993, Archives of disease in childhood.

Latent pulmonary function abnormalities in children with Crohn's disease.

J. Navarro, A. Munck, D. Murciano, 1995, The European respiratory journal.

Prevention of relapse by mesalazine (Pentasa) in pediatric Crohn's disease: a multicenter, double-blind, randomized, placebo-controlled trial.

J. Sarles, J. Mary, D. Turck, 2009, Gastroenterologie clinique et biologique.

Unique Tracheal Fluid MicroRNA Signature Predicts Response to FETO in Patients With Congenital Diaphragmatic Hernia

M. Post, D. Tibboel, R. Rottier, 2015, Annals of surgery.

Unique Tracheal Fluid MicroRNA Signature Predicts Response to enital Diaphragmatic Hernia FETO in Patients With Cong

M. Post, D. Tibboel, R. Rottier, 2015 .

G970R‐CFTR Mutation (c.2908G>C) Results Predominantly in a Splicing Defect

P. Negulescu, R. Vries, S. Boj, 2020, Clinical and translational science.

Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST).

Ying Jiang, Barry Plant, Matthias Griese, 2014, The Lancet. Respiratory medicine.

Pharmacokinetics of intravenous methylprednisolone and oral prednisone in paediatric patients with inflammatory bowel disease during the acute phase and in remission

J. Cézard, C. Faure, A. Munck, 1998, European Journal of Clinical Pharmacology.

Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation.

P. Hiatt, K. De Boeck, A. Munck, 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

WS18.5 Evaluation of the contributions of splicing and gating defects to dysfunction of G970R-CFTR

P. Negulescu, R. Vries, S. Boj, 2017 .

Tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for minimal function CFTR mutations.

C. Owen, E. Kerem, C. Wainwright, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Duodenal manometry in postobstructive enteropathy in infants with a transient enterostomy.

J. Cézard, C. Faure, Y. Aigrain, 1993, Journal of pediatric surgery.

Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport.

Milan Macek, Gérard Lenoir, J. Sarles, 2010, American journal of respiratory and critical care medicine.

Comprehensive CFTR gene analysis of the French cystic fibrosis screened newborn cohort: implications for diagnosis, genetic counseling, and mutation-specific therapy

M. Claustres, C. Férec, M. Audrézet, 2014, Genetics in Medicine.

357 Survey of the information provided for parents about newborn screening for CF in European programmes

C. Castellani, A. Munck, K. Southern, 2007 .

Inhaled tobramycin nebulizer solution for treatment of early Pseudomonas aeruginosa infection: the ELITE study

S. Stenglein, F. Ratjen, A. Munck, 2008 .

100 Safety of inhaled tobramycin nebuliser solution for treatment of early Pseudomonas aeruginosa infection: First results from the ELITE study

A. Munck, E. Ratjen, V. Campello, 2006 .

Cystic fibrosis: evidence for gut inflammation.

A. Munck, 2014, The international journal of biochemistry & cell biology.

Short Communication Recurrent abdominal pain in children with cystic fibrosis: A pilot prospective longitudinal evaluation of characteristics and management

C. Wood, A. Munck, M. Gerardin, 2012 .

Recurrent abdominal pain in children with cystic fibrosis: a pilot prospective longitudinal evaluation of characteristics and management.

C. Wood, A. Munck, M. Gerardin, 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Energy balance and nutritional support in cystic fibrosis

V. Varille, J. Navarro, A. Munck, 1995, Pediatric pulmonology. Supplement.

A new highly discriminatory multiplex capillary-based MLVA assay as a tool for the epidemiological survey of Pseudomonas aeruginosa in cystic fibrosis patients

D. Sobral, G. Vergnaud, E. Bingen, 2012, European Journal of Clinical Microbiology & Infectious Diseases.

P265 Real-life initiation of lumacaftor/ivacaftor in adolescents and adults homozygous for the F508del CFTR mutation: a French nationwide study

P. Reix, P. Burgel, I. Durieu, 2019, Journal of Cystic Fibrosis.

WS11.6 Newborn screening for cystic fibrosis: Rationale for p.Arg117His (R117H) removal from the CFTR mutation panel in France

C. Thauvin-Robinet, M. Audrézet, E. Girodon, 2015 .

264 Clinical outcome and social parameters impact on sport activity in children with CF: a prospective survey

A. Munck, I. Zaccaria, M. Gerardin, 2007 .

[Primary intestinal lymphangiectasis with antenatal manifestation].

J. Navarro, A. Munck, P. Foucaud, 1986, Archives francaises de pediatrie.

[Newborn screening for cystic fibrosis in France].

M. Audrézet, A. Munck, D. Cheillan, 2021, Medecine sciences : M/S.

[Malnutrition and low bone mineralisation in adults with cystic fibrosis].

P. Marteau, A. Munck, X. Dray, 2006, Gastroentérologie Clinique et Biologique.

[Digestive and nutritional management].

D. Turck, J. Navarro, A. Munck, 2001, Archives de pédiatrie.

[Digestive and nutritional management of adults with cystic fibrosis].

P. Marteau, J. Navarro, A. Munck, 2000, Revue des maladies respiratoires.

[Nutritional management of cystic fibrosis in children].

J. Navarro, A. Munck, 2000, Archives de pédiatrie.

194 A French survey on gastro-oesophageal reflux in CF: need for guidance

A. Munck, E. Mas, J. Languepin, 2014 .

A new water-soluble oral vitamin E formulation in cystic fibrosis (CF) children

D. Turck, A. Munck, F. Huet, 2010 .

Is nasal polyposis in cystic fibrosis a direct manifestation of genetic mutation or a complication of chronic infection?

J. Navarro, A. Munck, P. Narcy, 1996, Rhinology.

Penetrance is a critical parameter for assessing the disease liability of CFTR variants.

C. Férec, I. Sermet-Gaudelus, M. Audrézet, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Novel mutation (A141D) in exon 4 of the CFTR gene identified in an Algerian patient

E. Denamur, L. Gouya, J. Elion, 1997, Human mutation.

14 Updated survey of newborn screening for cystic fibrosis

O. Sommerburg, C. Castellani, J. Dankert-Roelse, 2014 .

ECFS best practice guidelines: the 2018 revision.

C. Castellani, P. Dřevínek, S. Bell, 2018, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

B. Kerem, J. Zieleński, P. Pignatti, 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Does newborn screening influence the young cystic fibrosis cohort included in national registries?

K. De Boeck, A. Munck, V. Gulmans, 2017, European Respiratory Journal.

Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial

F. Ratjen, A. Munck, G. Angyalosi, 2009, Thorax.

In situ management and molecular analysis of candidaemia related to a totally implantable vascular access in a cystic fibrosis patient.

A. Munck, C. Doit, S. Bonacorsi, 1996, The Journal of infection.

Recommendations for the classification of diseases as CFTR-related disorders.

B. Kerem, J. Zieleński, P. Pignatti, 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Defining key outcomes to evaluate performance of newborn screening programmes for cystic fibrosis.

O. Sommerburg, C. Castellani, M. Proesmans, 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Letter to the editor: Risk of false newborn screening after intra-uterine exposure to ETI.

C. Castellani, A. Munck, N. Simmonds, 2023, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

34* Cystic fibrosis newborn screened false-negative cohort: a national long term survey

A. Munck, E. Houssin, M. Roussey, 2011 .

Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis

P. Lebecque, N. Derichs, I. Sermet, 2009, Thorax.

A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis.

C. Castellani, I. Sermet, M. Schwarz, 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.